Dr. Merit Cudkowicz is the Julienne Dorn Professor of Neurology at Massachusetts General Hospital, at Harvard Medical School. Dr. Cudkowicz earned her Bachelors of Science degree in Chemical Engineering at the Massachusetts Institute of Technology and completed medical training at the Health Science and Technology program of Harvard Medical School. She obtained a Master’s degree in Clinical Epidemiology from the Harvard School of Public Health. She was a Resident and Chief Resident in Neurology at Massachusetts General Hospital (MGH).

Dr. Cudkowicz’s research and clinical activities are dedicated to the study and treatment of patients with neurodegenerative disorders, in particular amyotrophic lateral sclerosis (ALS). Dr. Cudkowicz directs the MGH ALS clinic and the MGH Neurology Clinical Trials Unit. She is one of the founders and co-directors of the Northeast ALS Consortium, a group of 100 clinical sites in the United States and Canada dedicated to performing collaborative academic led clinical trials in ALS. In conjunction with the NEALS consortium, she planned and completed many multi-center clinical trials in ALS and is currently leading three new trials in ALS. Dr. Cudkowicz received the American Academy of Neurology 2009 Sheila Essay ALS award. Dr. Cudkowicz is the Principal Investigator for the Clinical Coordination Center for NeuroNext, a new National Institute of Health initiated to expedite therapy development for neurological disorders.

Clinical Coordinating Center

Merit Cudkowicz, MD, MS, CCC Principal Investigator